Thompson SCI is commercializing a patented device based therapy for the treatment of traumatic Spinal Cord Injury (SCI) and the prevention of perioperative SCI. We will help patients that currently have no clinically effective treatment option.

Our therapy fits within current surgical techniques to inhibit the neurological and cytological responses that result in permanent neural disruption. It is an elegant solution that works as an adjunct with existing spinal implants.

The science behind this technology is supported by numerous peer-reviewed studies and is used to treat other pathologies today. Our system has been demonstrated in multiple pre-clinical trials and the next phase of studies, the precursors to human use, are being conducted over the next twelve months.

Overview

Total FundingEmployeesLast Funding DateStatus
$50,0001-102013-10-30Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2013-10-30$50,000SeedMassChallenge